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ABSTRACT
Aims To explore the association between cannabis and personality scores when genetic background and shared
environment are controlled for. Design The co-twin control design. This design provides a powerful method for
controlling for the effects of potentially confounding familial factors that may act to predispose subjects both to
cannabis use and a particular personality profile. Participants 118 monozygotic twin pairs discordant for cannabis
use.Measurements Data on personality and cannabis use were obtained through a questionnaire survey. The Dutch
Sensation Seeking List was used to assess various aspects of sensation seeking. The Amsterdamse Biografische Vragen-
lijst assessed extraversion, neuroticism, somatic complaints and test attitude. Findings The affected twins scored
higher on all scales than their unaffected co-twins, especially on experience seeking (P = 0.004), total sensation
seeking score (P = 0.004) and neuroticism (P = 0.039). Differences were also observed when items on drug use were
removed from the experience seeking scale (P = 0.037) and total sensation seeking score (P = 0.009) although these
differences were no longer significant after Bonferoni correction (P < 0.005). Conclusions Cannabis use is associated
with a higher score on personality scales. This result was obtained in a sample of monozygotic twins discordant for
cannabis use. Thus, at least part of the association between cannabis use and experience seeking cannot be attributed
to underlying genetic or shared environmental factors that influence both personality and cannabis use and must be
explained by unique environmental influences.
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INTRODUCTION
In the Netherlands, the term ‘soft drugs’ is used for sub-
stances that are readily available such as the psychedelic
mushrooms and cannabis products like hash and mari-
juana and are regarded as distinctly less harmful than
hard drugs such as cocaine and heroin (as defined in the
Dutch Opium Act).
The soft drugmost commonly used in the Netherlands
is cannabis, with the prevalence of lifetime use at
12–21% [1–3]. The lifetime prevalence of hallucinogenic
mushrooms is 2.6% in the Dutch population [2].
Cannabis use is associated with increased risk for the
subsequent use of more harmful drugs such as cocaine
and heroin [1,4–7], just like alcohol and tobacco use
appear to act as a gateway to cannabis use [7]. These
associations may reflect correlated risks, such as genetic
risk factors that influence the liability to use any drug or
environmental risk factors like social availability of
drugs, or these associationsmay reflect a causal influence
of cannabis on subsequent hard drug use, e.g. pharma-
cological effects of cannabis increase the liability to use
hard drugs [4,8,9].
Differences between cannabis users and non-users are
not limited to substance use alone. Compared to non-
users, cannabis users score higher on novelty seeking
[10] and sensation seeking [11], develop more often a
psychosis or psychotic symptoms [12,13] and showmore
suicidal behaviour [9].
A possible hypothesis to explain the association
between cannabis use and personality traits is that
genetic and/or shared environmental factors influence
both the risk of cannabis use and certain personality
traits. The individual variation in cannabis use is
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influenced by genetic factors with heritability estimates
ranging from 0.17 to 0.72 [14–17], and studies have
indeed shown that the association between cannabis use
and personality traits is at least partly explained
by common genetic factors [10,18]. However, these
common genetic factors do not explain all variances in
cannabis use. The present paper intends to shed more
light into the mechanism underlying the association
between cannabis use and personality by determining
whether this association still exists when controlling for
influences of genes and shared environment. To this aim
weuse a powerfulmethod, namely the discordant co-twin
design, which studies discordant monozygotic (MZ) twin
pairs by comparing the personality score of the affected
twin, who has used cannabis, to that of his or her non-
affected co-twin, who has never used cannabis. In this
design, genetic and common environmental influences
are controlled for becauseMZ twins share all their genetic
material and their (early) home environment. If the asso-
ciation between cannabis use and personality traits is
solely explained by genes and/or shared environmental
factors, then the twins who initiated cannabis use should
have the same personality score as their co-twins who did
not initiate cannabis use. In contrast, if the association is
to some extent causal or explained by environmental
factors for which twin pairs are discordant, we would
expect to find significantly different scores in the cannabis
users compared to their unaffected MZ co-twins.
METHODS
Subjects
The data used for this study are obtained from an ongoing
twin family study on health and lifestyle of the Nether-
landsTwin Register (NTR) [19,20]. Since 1991 question-
naires have been sent out every 2–3 years to Dutch twins
and their families. For this study we focused on the data
from the 2000 survey, which was completed by 4609
twins [21] of which 3890 remained after selecting only
twins aged 21 years and older. We excluded participants
under the age of 21 years to decrease the risk of misclas-
sification since differences within twin pairs in substance
use may change rapidly at a young age. Within this
sample, the prevalence of cannabis use (ever used) was
24.4% (31.9% for men and 22.2% for women). Using
only complete twin pairs, that is those twin pairs with
data available for both members of the twin pair, resulted
in a sample of 516 MZ female pairs and 195 MZ male
pairs. For most pairs, bothmembers of the pair had never
used cannabis: 370 female pairs (72%) and 120 male
pairs (61%). In some pairs, both twins had used cannabis:
64 female pairs (12%) and 39 male pairs (20%). The
remaining pairs, 82 female twin pairs (16%) and 36male
twin pairs (18%), were discordant for cannabis use.
Zygosity was based on DNA tests (n = 32 pairs) or on
questions concerning similarity (n = 86 pairs). Agree-
ment between zygosity based on questionnaire data and
zygosity based on DNA is 97% in the total sample. The
twins were on average 29.70 years old (SD = 8.92, range
from 21 to 67 years).
Variables
The use of cannabis was assessed in a survey on lifestyle,
health and personality. Subjects were asked to indicate at
what age they used the drugs and substances listed below
for the first time. The instruction they were given was
‘The list below gives a number of drugs and other sub-
stances people may use (cigarettes, alcohol, etc.). If you
have ever used any of the substances listed below, please
indicate the age at which you used them for the first
time.’. Items in the list were as follows: a) Smoked your
first cigarette, b) Regularly smoked cigarettes, c) Tried an
alcoholic drink, d) Regularly drank alcohol, e) Experi-
mented with soft drugs (e.g. hash, marijuana, magic
mushrooms, etc.), f) Regularly used soft drugs, g) Experi-
mented with ‘party drugs’ (e.g. MDMA, a synthetic, psy-
choactive drug. Street names for MDMA include ecstasy
or XTC), h) Regularly used ‘party drugs’, i) Experimented
with hard drugs (e.g. cocaine, LSD, pep pills, speed, etc.),
j) Regularly used hard drugs. The answer categories for
each of these items from the list were: first use at 11 years
or younger, at the age of 12–13, at the age of 14–15, at
the age of 16–17, at the age of 18 or older, or never used.
The variable ‘experimented with soft drugs’ was recoded
into ever used cannabis or never used cannabis.
The Dutch Sensation Seeking List [22] was used to
assess various aspects of sensation seeking; thrill adven-
ture seeking, experience seeking, boredom susceptibility
and disinhibition. Since the subscale experience seeking
contains two items on drug use, we performed the analy-
ses of the total score and the experience seeking subscale
bothwith andwithout those items. Extraversion, neuroti-
cism, somatic complaints and test attitude of the Amster-
damse Biografische Vragenlijst (ABV) [23]were used.The
ABV is a 107 item self-report personality scale similar in
content to the Eysenck Personality Questionnaire [24].
The scale has demonstrated good reliability and external
validity [23].
Data analyses
Twin pairs were selected for this study if a MZ twin had
used cannabis (=affected twin) and the co-twin had never
used cannabis (=unaffected twin). The affected twin was
compared to the unaffected co-twin on sensation seeking
and other personality traits using paired-samples t-tests.
A Bonferroni correction was applied by dividing the
overall significance level a = 0.05 by the number of
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comparisons (0.05/11 = 0.005). The co-twin control
design is a special sort of case-control study. This design
provides a rigorous test of the hypothesis that cannabis
use is still associatedwith personality scores after control-
ling for family environment and genetic influences. For
MZ twin pairs raised together (as our sample was),
aspects of the home and family environment do not differ
and members of each pair are genetically identical. This
design is likely to achieve a more rigorous control of
potentially confounding covariates than reliance on sta-
tistical control of observed covariates assessed in non-
related individuals.
All statistical analyses were performed with the Statis-
tical Package for the Social Sciences (SPSS) version 11.5
for Windows.
RESULTS
Descriptives
Most of the twins who used cannabis experimented for
the first time at an age of 18 years or older (65%). Only
2% started at the age of 12–13 years old, 11% experi-
mented at the age of 14–15, and 22% were 16–17 years
old at the time of their first use. Of the 118 twins who
tried cannabis, 15 subjects (13%) also reported to have
used cannabis on a regular basis at some point in their
lives. The prevalence of other substance use, both licit
(smoking and alcohol use) and illicit (party drugs and
hard drugs), was higher in the affected than in the unaf-
fected co-twins (Table 1).
Personality
When comparing the twins on the subscales of the sen-
sation seeking questionnaire, the affected twins scored
higher on all scales (Table 2). The differences between the
average scores for thrill seeking, boredom susceptibility
and disinhibition were small and not significant. After
Bonferoni correction, the affected twins still scored sig-
nificantly higher than the unaffected twins on the expe-
rience seeking scale and the total sensation seeking score.
However, the experience seeking scale contains two items
Table 1 Prevalence (%) of other substance use in affected twins and their unaffected co-twins. Differences between affected twins and
their unaffected co-twin are tested with the McNemar test for paired samples (P-value in last column).
Affected twin Unaffected twin P-value
Ever tried soft drugs 100.0 0.0
Ever smoked a cigarette 89.9 72.0 0.000
Smoked regularly 60.9 41.7 0.000
Ever tried alcohol 100.0 100.0 –
Used alcohol regularly 88.6 79.0 0.043
Used soft drugs regularly 13.0 0.0 0.000
Tried party drugs (like XTC) 7.6 1.7 0.039
Used party drugs regularly 5.1 0.9 0.125
Tried hard drugs (like cocaine) 6.8 0.0 0.008
Used hard drugs regularly 5.1 0.0 0.031
XTC = ecstasy.
Table 2 Mean (standard deviation) of affected twins and their unaffected co-twins for the SBL subscales (thrill seeking, experience
seeking, boredom susceptibility and disinhibition) and the ABV subscales (extraversion, neuroticism, somatic complaints, test atti-
tude). Differences between affected twins and their unaffected co-twin are tested with paired t-test (P-value in last column).
Affected twin Unaffected twin P-value
Thrill seeking 36.2 (9.9) 35.8 (9.7) 0.636
Experience seeking 36.0 (9.1) 33.8 (7.9) 0.004*
Experience seeking without drugs items 32.9 (8.6) 31.4 (7.6) 0.037*
Boredom susceptibility 36.6 (7.3) 34.5 (8.0) 0.010
Disinhibition 32.0 (7.6) 30.6 (8.0) 0.084
Sensation seeking—total 11.1 (1.9) 10.6 (1.9) 0.004**
Sensation seeking—total without drugs items 11.2 (2.0) 10.8 (1.9) 0.009*
Extraversion 61.9 (14.7) 61.0 (15.7) 0.589
Neuroticism 52.4 (24.5) 48.0 (21.0) 0.039*
Somatic complaints 17.9 (4.6) 17.7 (5.0) 0.772
Test attitude 35.9 (8.6) 36.9 (8.9) 0.252
*P < 0.05; **P < 0.005 (significance level after Bonferoni correction). SBL = Spannings Behoefte Lijst [Sensation Seeking Questionnaire];
ABV=Amsterdamse Biografische Vragenlijst.
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on drug use. When analyses were repeated without those
items, both the score on experience seeking and the total
sensation seeking score were still higher in affected twins
compared to their unaffected co-twins, but not significant
after Bonferoni correction (P = 0.037 and P = 0.009,
respectively).
Affected twins also scored higher than their co-twins
on all scales of the ABV except test-attitude. The largest
difference was found for neuroticism scores. This differ-
ence was not significant after Bonferroni correction
(P = 0.039).
DISCUSSION
The current study explored the differences in personality
scores in MZ twin pairs discordant for cannabis use. The
twin pairs selected in this study are genetically identical
and shared their home and family environment. Our use
of the co-twin control method provides a powerful tool
for controlling for the effects of potentially confounding
familial factors (either genetic or environmental) that
may act to predispose persons both to cannabis use and a
particular pattern of personality scores.
The twins who used cannabis had more often used
other substances, both legal (alcohol and tobacco) and
illegal (party drugs and hard drugs), compared to their
MZ co-twins who never used cannabis. This is in accor-
dance with previous research (also using the co-twin
control methodology), which showed that rates of life-
time party drugs use and life time hard drugs use were
elevated in twins who used cannabis before the age of 18
compared to their co-twins who did not use cannabis
before the age of 18 [1,6].
The affected twins scored significantly higher on neu-
roticism, experience seeking and sensation seeking (total
score) than their unaffected co-twins. Differences were
also observedwhen items on drug usewere removed from
the experience seeking scale and total sensation seeking
score although the significance of the results was
reduced. Several studies have found an association
between personality scores and cannabis use [9,11–13].
Pedersen [11] demonstrated that different subdimensions
of sensation seeking were strong predictors of future
drug use in a sample of 553 adolescents aged
16–18 years. For example, experience seeking predicted
cannabis use in boys. However, epidemiological studies
with unrelated subjects do not correct for common
genetic factors that influence both personality and can-
nabis use. With the present study we demonstrated that
the differences in personality scores between twins who
used cannabis and their unaffected co-twins cannot
solely be explained by genetic influences and/or a shared
environment. A remaining question to be addressed by
future research is the mechanism leading to these differ-
ences in personality scores between genetically identical
users and non-users. Differences in cannabis use may
lead to personality differences or, vice versa, personality
differences may lead to differences in cannabis use. Alter-
native explanations are also possible, such as the exist-
ence of a third unique environmental factor that is
influenced directly or indirectly, e.g. through an effect on
genetic make-up, both personality and cannabis use. The
possible causal pathways underlying the relationship
between personality traits and cannabis use has not
received much attention but two papers have specifically
explored the causal relationship between cannabis use
and psychotic symptoms [25,26]. Results of these studies
were not in agreement; while Fergusson et al. [26] con-
cluded that cannabis use causes psychotic symptoms, the
results by Ferdinand et al. [25] pointed to a common vul-
nerability underlying both cannabis use and psychosis or
a bi-directional causal relationship. The pathways
causing cannabis use to be associated with personality
and psychological disorders therefore still remain to be
determined.
A potential limitation of the present study is that par-
ticipation in the survey study of the NTR is voluntary and
therefore may present a selection bias. However, the
prevalence of ever having used cannabis in our sample
(25.4%) is comparable to the prevalence of cannabis use
in a similar age group within the Dutch population as
reported for 2001 by the Netherlands National Drug
Monitor [27]. A second potential limitation is that self-
report data are obtained and it is possible that such
reports may be biased in some way. Still, research has
shown acceptable reliability and validity for self-reported
age of onset of cannabis use [28,29].
In conclusion, our MZ discordant comparison shows
that individual-specific environmental factors play a role
in the association between cannabis use and personality,
in particular sensation seeking.
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